An 8 Week Prospective, Multicenter, Randomized, Double-Blind, Active Control, Parallel Group Study to Evaluate the Efficacy and Safety of Aliskiren HCTZ Versus Amlodipine in African American Patients With Stage 2 Hypertension.
Phase of Trial: Phase IV
Latest Information Update: 01 May 2011
At a glance
- Drugs Aliskiren/hydrochlorothiazide; Amlodipine
- Indications Hypertension
- Focus Biomarker; Therapeutic Use
- Acronyms ATLAAST
- Sponsors Novartis
- 14 Mar 2010 Results presented at the 59th Annual Scientific Session of the American College of Cardiology (ACC 2010).
- 22 Jul 2009 Actual patient number (332) added as reported by ClinicalTrials.gov.
- 22 Jul 2009 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.